'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
16th April 2026 Uncategorised 0The anti-amyloid drug class has yielded some FDA approvals and plenty of failed candidates. Now, researchers are looking at the overall track record of the group and painting an unpleasant picture about the efficacy of these drugs.
More: 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
Source: fierce